(Q84588320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

main subject

thymocyte

0 references

kidney transplantation

1 reference

1

Junichiro Sageshima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Gaetano Ciancio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Giselle Guerra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jeffrey J Gaynor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Deborah Cova

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Alberto Zarak

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Linda Chen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Adela Mattiazzi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Warren Kupin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

David Roth

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Lois Hanson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Alan S Livingstone

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Phillip Ruiz

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

George W Burke

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

19 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

published in

Transplant Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

104-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

BAFF is increased in renal transplant patients following treatment with alemtuzumab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Alemtuzumab (Campath-1H) in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Acute cellular rejection predominated by monocytes is a severe form of rejection in human renal recipients with or without Campath-1H (alemtuzumab) induction therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Can acute rejection be prevented in SPK transplantation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Addition of anti-CD25 to thymoglobulin for induction therapy: delayed return of peripheral blood CD25-positive population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

The use of Campath-1H as induction therapy in renal transplantation: preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Favorable outcomes with machine perfusion and longer pump times in kidney transplantation: a single-center, observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Investigation of lymphocyte depletion and repopulation using alemtuzumab (Campath-1H) in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Long-term cell monitoring of kidney recipients after an antilymphocyte globulin induction with and without steroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Immune reconstitution following rabbit antithymocyte globulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

B-cell activity of polyclonal antithymocyte globulins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Memory T-cell predominance following T-cell depletional therapy derives from homeostatic expansion of naive T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

CD4+ regulatory T cells are spared from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

FOXP3+ regulatory T cells in the human immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

CD4+CD25high regulatory cells in human peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Control of regulatory T cell development by the transcription factor Foxp3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Transient regulatory T-cells: a state attained by all activated human T-cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: clinical outcomes and effect on T-regulatory cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Following anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.07.002

10.1016/J.TRIM.2011.07.002

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21784152%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference